SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030335
Filing Date
2019-08-08
Accepted
2019-08-07 20:48:18
Documents
55
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20190630.htm   iXBRL 10-Q 2393290
2 EX-31.1 fprx-ex311_10.htm EX-31.1 8729
3 EX-31.2 fprx-ex312_6.htm EX-31.2 8499
4 EX-32.1 fprx-ex321_8.htm EX-32.1 5335
5 EX-32.2 fprx-ex322_9.htm EX-32.2 5230
6 GRAPHIC gav2j0rbechq000001.jpg GRAPHIC 35710
  Complete submission text file 0001564590-19-030335.txt   7798024

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fprx-20190630.xsd EX-101.SCH 41051
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20190630_cal.xml EX-101.CAL 46454
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20190630_def.xml EX-101.DEF 133675
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20190630_lab.xml EX-101.LAB 372021
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20190630_pre.xml EX-101.PRE 267113
12 EXTRACTED XBRL INSTANCE DOCUMENT fprx-10q_20190630_htm.xml XML 1546805
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 191007207
SIC: 2834 Pharmaceutical Preparations